Picture of MindMaze Therapeutics Holding SA logo

MMTX MindMaze Therapeutics Holding SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Relief Therapeutics Announces IRB Approval Of Investigator-Initiated Trial Evaluating RLF-TD011

Jan 17 (Reuters) - Relief Therapeutics Holding SA
 RLFB.S :
    * RELIEF THERAPEUTICS ANNOUNCES IRB APPROVAL OF
INVESTIGATOR-INITIATED TRIAL EVALUATING RLF-TD011 AS AN
ADJUNCTIVE TREATMENT FOR CUTANEOUS T-CELL LYMPHOM

Source text for Eikon:  ID:nEQXpJgja 
Further company coverage:  RLFB.S 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on MindMaze Therapeutics Holding SA

See all news